Business Concentrates: New England Peptide Debuts Instrument

Chemical & Engineering News


Monday 04 January 2010

Volume 88, Number 1, page 13


New England Peptide has launched a peptide synthesis instrument designed for the scale-up and process development of customers' peptide-based drugs. The Gardner, Mass.-based firm says it built PepScale using its chemistry knowledge at both the research and preclinical levels. The instrument is optimized to make tens of grams.


Article Location


"Over the past 8 years we have used NEP for synthesis of many hundreds of peptides. The quality of NEP’s product is consistently very high. The company is deeply knowledgeable in all aspects of peptide synthesis, highly collaborative, and keenly interested in meeting the changing needs of their customers with respect to scale and formatting for delivery of peptides. One example is their flash-purified product which meets the need for initial draft-level evaluation without breaking the bank. Our experience with NEP’s antibody production capabilities has also been very good..."
Steven Carr, PhD - Director of Proteomics, Broad Institute